CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 1868 | 2069 | 90.3% | |
| CKD 4 | 2008 | 2964 | 3330 | 89.0% | |
| CKD 5 | 2009 | 769 | 823 | 93.4% | |
| CKD 5 | 2010 | 620 | 666 | 93.1% | |
| CKD 5 | 2011 | 701 | 763 | 91.9% | |
| CKD 5 | 2012 | 772 | 860 | 89.8% | |
| CKD 5 | 2013 | 766 | 843 | 90.9% | |
| CKD003 | 2014 | 774 | 843 | 91.8% | |
| CKD003 | 2015 | 734 | 812 | 90.4% | |
| CKD003 | 2016 | 702 | 789 | 89.0% |
